BofA Securities Maintains Haleon(HLN.US) With Buy Rating
Berenberg Bank Maintains Haleon(HLN.US) With Buy Rating, Raises Target Price to $11.79
Haleon PLC (HLN) Gets a Hold From Kepler Capital
Haleon PLC: Projected Organic Sales Growth and Market Consensus Drive Positive Outlook and Buy Rating
UBS Reaffirms Their Buy Rating on Haleon PLC (HLN)
Haleon Is Maintained at Overweight by Morgan Stanley
Haleon Analyst Ratings
Morgan Stanley Maintains Haleon(HLN.US) With Buy Rating, Raises Target Price to $10.95
Haleon PLC (HLN) Receives a Buy From Jefferies
BofA Securities Initiates Haleon(HLN.US) With Buy Rating
Bank of America Securities Remains a Buy on Haleon PLC Sponsored ADR (HLN)
Berenberg Bank Initiates Haleon(HLN.US) With Buy Rating, Announces Target Price $11.44
Berenberg Initiates Haleon at Buy With $11.44 Price Target
Haleon PLC: Solid Performance Balanced With Premium Valuation Leads to Neutral Rating
Haleon PLC: A Strong Buy on Resilient Growth and Robust Shareholder Returns
Kepler Capital Remains a Hold on Haleon PLC (HLN)
Barclays Keeps Their Buy Rating on Haleon PLC (HLN)
Haleon PLC: A Hold Rating Amid Solid Fundamentals and Cautious Optimism
Haleon Now Expects 2024 Operating Profit Growth to Grow High-Single Digit
Analysts Offer Insights on Healthcare Companies: Centene (CNC), Haleon PLC (GB:HLN) and Ultragenyx Pharmaceutical (RARE)
No Data
No Data